XHE - ETF AI Analysis
Top Page
SPDR S&P Health Care Equipment ETF (XHE)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Many of the largest positions have shown strong year-to-date gains, helping support the fund despite recent volatility.
Focused Health Care Exposure
The ETF is heavily invested in health care equipment companies, giving investors targeted exposure to a specialized part of the health care sector.
Moderate Expense Ratio
The fund’s fee is reasonable for a specialized sector ETF, so less of your potential return is lost to costs.
Negative Factors
Recent Weak Overall Performance
The ETF has delivered weak returns so far this year and over the last three months, which may concern investors looking for near-term strength.
Single-Sector Concentration
With almost all assets in health care, the fund is highly sensitive to downturns or regulatory changes affecting this one sector.
Limited Geographic Diversification
The portfolio is almost entirely invested in U.S. companies, offering little protection if the U.S. market or economy struggles.
XHE vs. SPDR S&P 500 ETF (SPY)
AUM123.95M
RegionNorth America
Expense Ratio0.35%
Beta0.83
IssuerSPDR
Inception DateJan 26, 2011
Dividend Yield0.12%
Asset ClassEquity
Index TrackedS&P Healthcare Equipment Select Industry
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume23,373
30 Day Avg. Volume27,034
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
103.69Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering66
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XHE Summary
XHE is an ETF that follows the S&P Health Care Equipment Select Industry Index, focusing on U.S. companies that make medical devices and supplies used in hospitals, clinics, and doctors’ offices. It holds a wide mix of health care equipment makers, including well-known names like Align Technology and Teleflex. Someone might invest in XHE to tap into the long-term growth of medical technology and to diversify within the health care sector. A key risk is that it is heavily focused on health care equipment stocks, so its price can rise or fall sharply with this specific industry.
How much will it cost me?The SPDR S&P Health Care Equipment ETF (XHE) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is a sector-focused fund, which often requires more active management compared to broad-market index funds. However, it provides targeted exposure to the innovative health care equipment industry.
What would affect this ETF?The SPDR S&P Health Care Equipment ETF (XHE) could benefit from increased demand for innovative medical technologies and devices, driven by aging populations and advancements in health care. However, it may face challenges from regulatory changes, rising interest rates that impact growth-focused companies, or economic slowdowns that reduce health care spending. Its U.S.-focused portfolio and reliance on the health care equipment sector make it sensitive to domestic policy shifts and sector-specific trends.
XHE Top 10 Holdings
XHE is a pure play on U.S. medical devices, with performance driven by a mix of fast climbers and a few names losing steam. Avanos Medical has been a standout, rising sharply and giving the fund a solid lift, while Butterfly Network and AxoGen add more momentum with improving sentiment around innovation and new approvals. Align Technology has been steadily contributing as demand for dental tech holds up. On the flip side, Artivion has been lagging and acting as a small drag. Overall, the ETF is tightly focused on health care equipment, with no big tech or international wildcards in the mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Staar Surgical | 2.82% | $3.44M | $1.59B | 67.84% | 46 Neutral | |
| NovoCure | 2.57% | $3.14M | $2.04B | -2.78% | 48 Neutral | |
| Glaukos | 2.35% | $2.87M | $8.46B | 48.34% | 61 Neutral | |
| AxoGen | 2.26% | $2.76M | $2.18B | 256.72% | 69 Neutral | |
| Avanos Medical | 2.16% | $2.64M | $1.16B | 90.45% | 52 Neutral | |
| Teleflex | 2.07% | $2.53M | $5.74B | 1.78% | 68 Neutral | |
| Omnicell | 2.07% | $2.53M | $1.96B | 55.19% | 71 Outperform | |
| Lantheus | 2.04% | $2.49M | $6.11B | 19.02% | 73 Outperform | |
| LivaNova | 2.01% | $2.45M | $3.85B | 64.27% | 63 Neutral | |
| Solventum Corporation | 1.97% | $2.40M | $12.86B | 0.48% | 73 Outperform |
XHE Technical Analysis
Neutral
―
Price Trends
80.15
Negative
83.87
Negative
83.05
Negative
Market Momentum
-0.79
Positive
47.71
Neutral
32.40
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XHE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 80.03, equal to the 50-day MA of 80.15, and equal to the 200-day MA of 83.05, indicating a bearish trend. The MACD of -0.79 indicates Positive momentum. The RSI at 47.71 is Neutral, neither overbought nor oversold. The STOCH value of 32.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for XHE.
XHE Peer Comparison
Comparison Results
Performance Comparison
XHE
SPDR S&P Health Care Equipment ETF
81.02
0.31
0.38%
IHE
iShares U.S. Pharmaceuticals ETF
―
―
―
FXH
First Trust Health Care AlphaDEX Fund
―
―
―
IHF
iShares U.S. Healthcare Providers ETF
―
―
―
RSPH
Invesco S&P 500 Equal Weight Health Care ETF
―
―
―
XPH
SPDR S&P Pharmaceuticals ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents